Literature DB >> 27200682

Cost-Effectiveness of Empagliflozin (Jardiance®) 10 Mg And 25 Mg Administered As An Add-On To Metformin And Sulfonilurea (Met+Su) Compared To Other Sodium-Glucose Co-Transporter 2 Inhibitors (Sglt2is) in Patients with Type 2 Diabetes Mellitus (T2dm) In The Uk.

R Aguiar-Ibáñez1, R Palencia2, P Kandaswamy3, L Li1.   

Abstract

Entities:  

Year:  2014        PMID: 27200682     DOI: 10.1016/j.jval.2014.08.732

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  1 in total

1.  Empagliflozin in Type 2 Diabetes Mellitus Patients with High Cardiovascular Risk: A Model-Based Cost-Utility Analysis in China.

Authors:  Peng Men; Tianbi Liu; Suodi Zhai
Journal:  Diabetes Metab Syndr Obes       Date:  2020-08-11       Impact factor: 3.168

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.